News

In mesmerizing new videos, single atoms move and shake during a chemical reaction that removes hydrogen atoms from an alcohol molecule. By viewing the process in real time, the researchers discovered ...
This video shows a fleeting hemiacetal alkoxide intermediate, which the researchers, unprecedentedly, captured. The team also observed its reverse aldehyde elimination, generating an aldehyde and a ...
Scientists have captured the first-ever video of atoms in motion during a chemical reaction, revealing hidden pathways and short-lived molecules previously impossible to observe. Using a new type of ...
The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
Aldeyra Therapeutics, Inc.’s ALDX share price has surged by 23.94%, which has investors questioning if this is right time to sell.
The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.
The next installment of my reading wrap-up is here! After a first two successful months of reading, I contemplated what was ...
In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...
The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of ...